Harbor Health Care

Global healthcare companies

(WELP)

£5.40

Previous business day’s close price

‑£0.59 (‑9.91%)

max available period

£4.79

£8.75

08 Apr 19

13 Dec 24

Details

ETF description

This ETF invests in companies that are involved in the healthcare industry, focusing on sectors experiencing rapid growth and innovation. The fund targets businesses that are developing cutting‑edge technologies, products, and services in areas such as biotechnology, medical devices, pharmaceuticals, and healthcare services.

This ETF may appeal to investors who are interested in the healthcare sector and are looking for exposure to companies driving innovation in medical science and healthcare delivery. The fund offers an equal‑weight approach, ensuring balanced exposure to each company within its portfolio.

Issuer details

HanETF is an independent asset management firm known for being the first independent white‑label ETF platform in Europe. With over $4 billion in assets under management as of June 2024, HanETF offers a diverse range of ETFs. Established in 2017 by Hector McNeil and Nik Bienkowski, HanETF focuses on providing market exposures through collaboration with asset managers to bring investment ideas to market.

Index details

The Healthcare ETF is actively managed by the expert team at Westfield Capital Management.

Westfield Capital uses a bottom‑up process to identify companies that meet their strict fundamental criteria and then performs a qualitative review on each identified company to select approximately 30 to 50 companies for inclusion in the active Healthcare ETF’s portfolio. The Subadvisor’s research may include personal interviews and other contact with company management.

This ETF is in collections:

Thematics

Healthcare

Key information

Key investor information

ETF Breakdown

Ascendis Pharma A/S

9.7%

Legend Biotech Corp

8.0%

Dexcom Inc

4.8%

Lantheus Holdings Inc

4.7%

Pfizer Inc.

4.1%

Novo Nordisk

3.5%

Abbvie Inc

3.4%

Insulet Corporation

3.0%

Vaxcyte Inc

2.9%

Masimo Corp

2.6%

argenx SE

2.5%

Bicycle Therapeutics Plc

2.3%

Lilly

2.2%

Icon Plc

2.0%

Glaukos Corporation

1.9%

Ge Healthcare Technologies Inc

1.5%

Intra‑Cellular Therapies Inc

1.5%

Unitedhealth Group Inc

1.4%

Bio‑Rad Laboratories Inc.

1.4%

Illumina Inc

1.3%

Boston Scientific Corp.

1.3%

Moonlake Immunotherapeutics Class A

1.1%

Option Care Health Inc.

1.1%

iRhythm Technologies Inc

1.0%

Oscar Health Inc

0.8%

Cytokinetics Inc

0.7%

Revolution Medicines Inc

0.7%

Procept BioRobotics Corp

0.6%

89bio Inc

0.6%

Cooper Inc

0.6%

Natera Inc

0.5%

Vertex Pharmaceuticals, Inc.

0.5%

Xenon Pharmaceuticals Inc

0.5%

Edgewise Therapeutics Inc

0.5%

Haemonetics Corp.

0.3%

Merus N.V

0.1%

Soleno Therapeutics Inc

< 0.1%

Others

0.4%

£5.40

Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 700+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
Browse investments

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.

ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.